Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Travere Therapeutics (TVTX) Preferred Shares: 2012

Travere Therapeutics' Preferred Shares was N/A to $1 in Q4 2012 from the same period last year, while for Nov 2012 it was $1, marking a year-over-year change of. This contributed to the annual value of $1 for FY2012, which is N/A change from last year.
According to the latest figures from Q4 2012, Travere Therapeutics' Preferred Shares is $1, which was down 0.00% from $1 recorded in Q1 2012.
Travere Therapeutics' 5-year Preferred Shares high stood at $1 for Q1 2012, and its period low was $1 during Q1 2012.
In the last 1 years, Travere Therapeutics' Preferred Shares had a median value of $1 in 2012 and averaged $1.